Severe Pneumonia Clinical Trial
Official title:
Construction of Special Disease Cohort Database and Biological Sample Holographic Database of Severe Pneumonia
The incidence rate and mortality of lung infection are high worldwide. It is a common and frequently occurring disease which seriously threatens human health. Severe pneumonia accounts for 18-36% of all pneumonia. Severe pneumonia has caused serious economic and medical burden. Therefore, it is urgent to carry out the real-world cohort study of severe pneumonia. Big data and sample library will provide useful clinical guidance and scientific research reserves for clinicians. Through further research, we can improve the treatment success rate and reduce the mortality. The purpose of this study is to provide reliable biological samples and related data information for the relevant basic and clinical trials in the field of severe pneumonia by carrying out the construction of special disease cohort database and biological sample holographic database, and to establish a long-term sharing platform for the transformation of research results into clinical practice, improve the prognosis of severe pneumonia,and provide the evidence for improving the diagnosis and treatment of severe pneumonia suitable for China's national conditions.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06114784 -
Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study
|
||
| Completed |
NCT03870243 -
Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Children Aged 1-59 Months With Severe Pneumonia in Ethiopia
|
N/A | |
| Completed |
NCT05158842 -
Treatment of COVID-19 Positive/Negative Bangladeshi Adults With Severe Respiratory Complaints by a Locally Made bCPAP: Feasibility Study
|
N/A | |
| Suspended |
NCT04310865 -
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
|
Phase 2/Phase 3 | |
| Completed |
NCT04457505 -
One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19
|
||
| Terminated |
NCT04794803 -
Reparixin in COVID-19 Pneumonia - Efficacy and Safety
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01068990 -
Detection and Characterization of Lower Respiratory Infections in Critically Ill Patients
|
||
| Completed |
NCT03831906 -
Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)
|
N/A | |
| Recruiting |
NCT05768204 -
Research on the Treatment of Severe Community-acquired Pneumonia in Children
|
Phase 4 | |
| Recruiting |
NCT04359667 -
Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab
|
||
| Not yet recruiting |
NCT04395066 -
Molecular Diagnosis and Prognosis of Severe Pulmonary Infection Immunosuppressed Hosts
|
||
| Not yet recruiting |
NCT05143593 -
Species-specific Bacterial Detector for Fast Pathogen Diagnosis of Severe Pneumonia
|
N/A | |
| Completed |
NCT05663905 -
Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients
|
Phase 4 | |
| Not yet recruiting |
NCT04282928 -
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells for the Treatment of Severe Viral Pneumonian
|
Phase 1 | |
| Completed |
NCT01192789 -
Community Case Management of the Severe Pneumonia With Oral Amoxicillin in Children 2-59 Months of Age
|
N/A | |
| Completed |
NCT00455468 -
Randomized Controlled Trial (RCT) in Children With Severe Pneumonia
|
N/A | |
| Completed |
NCT03588377 -
Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia
|
N/A | |
| Recruiting |
NCT04955756 -
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
|
N/A | |
| Not yet recruiting |
NCT03891212 -
The Effect of Prone Position Drainage on the Efficacy of Severe Pneumonia，a Multicenter Randomized Controlled Trial
|
N/A |